Canadian Pacific sees FY13 non-GAAP EPS up 40% versus FY12 Sees FY13 revenue growth to be in the high single digits, operating ratio to be in the low 70s and diluted EPS to be up in excess of 40%t versus 2012's diluted EPS excluding significant items of $4.34. Guidance was issued this morning with the company's Q4 results.
Pershing Square says not selling Valeant a 'very costly mistake' In its Annual Investor Letter, Pershing Square said, in part, that not selling Valeant (VRX) was a "very costly mistake." It also noted that not trimming its Canadian Pacific (CP) stake was a "similar error," and that they paid too much for additional stock in Platform Specialty Products (PAH). Reference Link